Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson's Disease and Control Subjects

Journal of Parkinson's Disease

Volumn 6, Issue 4, 2016, Pages 761-770

  Beach, Thomas G ^a   Corbillé, Anne Gaëlle ^b,c,d,e,f   Letournel, Franck ^e,f   Kordower, Jeffrey H ^g   Kremer, Thomas ^h   Munoz, David G ⁱ   Intorcia, Anthony ^a   Hentz, Joseph ^j   Adler, Charles H ^j   Sue, Lucia I ^a   Walker, Jessica ^a   Serrano, Geidy ^a   Derkinderen, Pascal ^b,c,d  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

^b INSERM   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

^e ANGERS UNIVERSITY HOSPITAL   (France)

^f UNIVERSITÉ D'ANGERS   (France)

^g RUSH MEDICAL COLLEGE   (United States)

^h F HOFFMANN LA ROCHE LTD   (Switzerland)

ⁱ ST MICHAEL'S HOSPITAL   (Canada)

^j MAYO CLINIC   (United States)

more..

Author keywords

biopsy; diagnosis; enteric nervous system; gastrointestinal tract; Lewy body; pathology

Indexed keywords

ALPHA SYNUCLEIN;

AGED; ARTICLE; AUTOPSY; CLINICAL ARTICLE; COLON BIOPSY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; INTESTINE MUCOSA; INTESTINE MUSCLE; LEWY BODY; MALE; MULTICENTER STUDY; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SENSITIVITY AND SPECIFICITY; SIGMOID; SUBMUCOSA; SYMPTOM; YOUDEN INDEX; BIOPSY; CLINICAL TRIAL; METABOLISM; PATHOLOGY; PROCEDURES; STANDARDS;

ALPHA-SYNUCLEIN; BIOPSY; COLON, SIGMOID; HUMANS; IMMUNOHISTOCHEMISTRY; PARKINSON DISEASE;

EID: 84994113227     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-160888     Document Type: Article

References (38)

1. Qualman SJ, Haupt HM, Yang P, &Hamilton SR (1984) Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterology, 87, 848-856.
2. Kupsky WJ, Grimes MM, Sweeting J, Bertsch R, &Cote LJ (1987) Parkinson's disease and megacolon: Concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology, 37, 1253-1255.
3. Wakabayashi K, Takahashi H, Takeda S, Ohama E, &Ikuta F (1988) Parkinson's disease: The presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol, 76, 217-219.
4. Braak H, deVos RA, Bohl J,& Del TrediciK(2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett, 396, 67-72.
5. Lebouvier T, Chaumette T, Damier P, Coron E, TouchefeuY, Vrignaud S, Naveilhan P, Galmiche JP, Bruley des Varannes S, Derkinderen P,& NeunlistM(2008) Pathological lesions in colonic biopsies during Parkinson's disease. Gut, 57, 1741-1743.
6. Beach TG1, Adler CH, Sue LI, Vedders L, Lue L, White III CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG, &Arizona Parkinson's Disease, Consortium (2009) Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol, 119, 689-702.
7. Lebouvier T, Coron E, Chaumette T, Paillusson S, Bruley des Varannes S, Neunlist M, &Derkinderen P (2010) Routine colonic biopsies as a new tool to study the enteric nervous system in living patients. Neurogastroenterol Motil, 22, e11-e14.
8. Lebouvier T, Neunlist M, Bruley des Varannes S, Coron E, Drouard A, N'Guyen JM, Chaumette T, Tasselli M, Paillusson S, Flamand M, Galmiche JP, Damier P, &Derkinderen P (2010) Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLoS One, 5, e12728.
9. Lebouvier T, Tasselli M, Paillusson S, Pouclet H, Neunlist M, Derkinderen P (2010) Biopsable neural tissues: Toward new biomarkers for Parkinson's disease? Front Psychiatry 1, 128.
10. Shannon KM, Keshavarzian A, Mutlu E, Dodiya HB, Daian D, Jaglin JA, &Kordower JH (2012) Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Mov Disord, 27, 709-715.
11. Pouclet H, Lebouvier T, Coron E,Varannes des SB, Neunlist M, &Derkinderen P (2012) A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson's disease. Neurogastroenterol Motil, 24, e202-e205.
12. Annerino DM, Arshad S, Taylor GM, Adler CH, Beach TG, &Greene JG (2012) Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss. Acta Neuropathol, 124, 665-680.
13. Hilton D, Stephens M, Kirk L, Edwards P, Potter R, Zajicek J, Broughton E, Hagan H,& Carroll C (2013) Accumulation of --synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease. Acta Neuropathol, 127, 235-241.
14. Gold A, Turkalp ZT, &Munoz DG (2013) Enteric alphasynuclein expression is increased in Parkinson"s disease but not Alzheimers disease. Mov Disord, 28, 237-240.
15. Gelpi E, Navarro-Otano J, Tolosa E, Gaig C, Compta Y, Rey MJ, Martí MJ, Hernández I, Valldeoriola F, René R, &Ribalta T (2014) Multiple organ involvement by alphasynuclein pathology in Lewy body disorders. Mov Disord, 29, 1010-1018.
16. Masuda H, Asahina M, Oide T, Wakita H, Sekiguchi Y, Araki N, &Kuwabara S (2014) Antemortem detection of colonic --synuclein pathology in a patient with pure autonomic failure. J Neurol, 261, 2451-2452.
17. Visanji NP, Marras C, Hazrati L-N, Liu LWC, &Lang AE (2014) Alimentary, my dear Watson? The challenges of enteric --synuclein as a Parkinson's disease biomarker. Mov Disord, 29, 444-450.
18. Schneider SA, Boettner M, Alexoudi A, Zorenkov D, Deuschl G, & Wedel T (2015) Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature. Eur J Neurol, 23, 247-261.
19. Visanji NP, Marras C, Kern DS, Dakheel Al A, Gao A, Liu LW, Lang AE,& Hazrati LN (2015) Colonic mucosal alphasynuclein lacks specificity as a biomarker for Parkinson disease. Neurology, 84, 609-616.
20. Chung SJ, Kim J, Lee HJ, Ryu H-S, Kim K, Lee JH, Jung KW, Kim MJ, Kim MJ, Kim YJ, Yun SC, Lee JY, Hong SM, &Myung SJ (2015) Alpha-synuclein in gastric and colonic mucosa in Parkinson's disease: Limited role as a biomarker. Mov Disord, 31, 241-249.
21. Woulfe JM, Gray MT, &Munoz G (2015) Colonic mucosal --synuclein lacks specificity as a biomarker for Parkinson disease. Neurology, 85, 834.
22. Unger MM, &Sakakibara R (2015) Does REM sleep behavior disorder have the guts to be Parkinson disease?. Neurology, 85, 1732-1733.
23. Sprenger FS, Stefanova N, Gelpi E, Seppi K, Navarro-Otano J, Offner F, Vilas D, Valldeoriola F, Pont-Sunyer C, Aldecoa I, Gaig C, Gines A, Cuatrecasas M, Högl B, Frauscher B, Iranzo A,Wenning GK, VogelW, Tolosa E, &PoeweW (2015) Enteric nervous system --synuclein immunoreactivity in idiopathic REM sleep behavior disorder. Neurology, 85, 1761-1768.
24. Ruffmann C, &Parkkinen L (2015) Colonic mucosal --synuclein lacks specificity as a biomarker for Parkinson disease. Neurology, 85, 834.
25. Cersosimo MG (2015) Gastrointestinal biopsies for the diagnosis of alpha-synuclein pathology in Parkinson's disease. Gastroenterol Res Pract, 2015, 476041.
26. Xuan Q, Zhang YX, Liu DG, Chan P, Xu SL, &Cui YQ (2016) Post-translational modifications of --synuclein contribute to neurodegeneration in the colon of elderly individuals. Mol Med Rep, 13, 5077-5083.
27. Stokholm MG, Danielsen EH, Hamilton-Dutoit SJ, &Borghammer P (2016) Pathological alpha-synuclein in gastrointestinal tissues from prodromal parkinson's disease patients. Ann Neurol, 79, 940-949.
28. Corbillé AG, Letournel F, Kordower JH, Lee J, Shanes E, Neunlist M, Munoz DG, Derkinderen P, &Beach TG (2016) Evaluation of alpha-synuclein immunohistochemical methods for the detection of Lewy-type synucleinopathy in gastrointestinal biopsies. Acta Neuropathol Commun, 4, 35.
29. Adler CH, Beach TG, Hentz JG, Shill HA, Caviness JN, Driver-Dunckley E, Sabbagh MN, Sue LI, Jacobson SA, Belden CM, &Dugger BN (2014) Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study. Neurology, 83, 406-412.
30. Beach TG, Adler CH, Sue LI, Serrano G, Shill HA,Walker DG, Lue L, Roher AE, Dugger BN, Maarouf C, BirdsillAC, Intorcia A, Saxon-Labelle M, Pullen J, Scroggins A, Filon J, Scott S, Hoffman B, Garcia A, Caviness JN, Hentz JG, Driver-Dunckley E, Jacobson SA, Davis KJ, Belden CM, Long KE, Malek-Ahmadi M, Powell JJ, Gale LD, Nicholson LR, Caselli RJ, Woodruff BK, Rapscak SZ, Ahern GL, Shi J, Burke AD, Reiman EM, &Sabbagh MN (2015) Arizona study of aging and neurodegenerative disorders and brain and body donation program. Neuropathology, 35, 354-389.
31. Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J, White CL, 3rd, Akiyama H, Caviness J, Shill HA, Connor DJ, Sabbagh MN, Walker DG, &Arizona Parkinson's Disease Consortium (2009) Unified staging system for Lewy body disorders: Correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol, 117, 613-634.
32. Waxman EA, &Giasson BI (2008) Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein. J Neuropathol Exp Neurol, 67, 402-416.
33. Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, &Iwatsubo T (2002) Alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol, 4, 160-164.
34. Obi K, Akiyama H, Kondo H, Shimomura Y, Hasegawa M, Iwatsubo T, Mizuno Y,& Mochizuki H (2008) Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies. Exp Neurol, 210, 409-420.
35. Walker DG, Lue LF, Adler CH, Shill HA, Caviness JN, Sabbagh MN, Akiyama H, Serrano GE, Sue LI, Beach TG, &Arizona Parkinson Disease, Consortium (2013) Changes in properties of serine 129 phosphorylated alpha-synuclein with progression of Lewy-type histopathology in human brains. Exp Neurol, 240, 190-204.
36. Beach TG, White CL, Hamilton RL, Duda JE, Iwatsubo T, Dickson DW, Leverenz JB, Roncaroli F, Buttini M, Hladik CL, Sue LI, Noorigian JV, &Adler CH (2008) Evaluation of alpha-synuclein immunohistochemical methods used by invited experts. Acta Neuropathol, 116, 277-288.
37. Schell H, Hasegawa T, Neumann M, &Kahle PJ (2009) Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice. Neuroscience, 160, 796-804.
38. Giasson BI, Uryu K, Trojanowski JQ, &Lee VM (1999) Mutant and wild type human alpha synucleins assemble into elongated filaments with distinct morphologies in vitro. J Biol Chem, 274, 7619-7622.